History and Countermeasure Discovered from 40-year Development of Laboratory Animals in Yunnan Province

doi:10.12300/j.issn.1674-5817.2021.136

Abstract

Abstract: Laboratory animals are strategic resources that are indispensable to support scientific and technological progress and innovation. It is one of the core elements required for country to maintain scientific and technological leadership and improve international scientific and technological competitiveness. In this study, the legalization and standardization, major research institutions, scientific research features and academic achievements, and current opportunities and countermeasures over 40 years of progression of laboratory animals in Yunnan Province were summarized to provide a reference for the further development of laboratory animals in China.

Key words: Yunnan Province, Laboratory animal, Progression of development, Countermeasures

CLC Number:

Q95-33
R-332

HAN Yuanyuan, LI Na, DAI Jiejie. History and Countermeasure Discovered from 40-year Development of Laboratory Animals in Yunnan Province[J]. Laboratory Animal and Comparative Medicine, 2021, 41(5): 399-408.

References

[1] 李小群, 陈朔阳. 建设昆明国际实验动物产业园打造云南省经济发展新增长极[J]. 云南科技管理, 2018, 31(2):19-22. DOI:10.19774/j.cnki.53-1085.2018.02.005.
[2] 刘佳, 李娟, 王学伟, 等. 云南省实验动物现状中存在的问题及解决策略[J]. 世界最新医学信息文摘, 2016, 16(86):58-59.
[3] 涂文姬, 吴志晖, 肖军, 等. 云南省人工繁育野生动物产业类型调查分析[J]. 林业调查规划, 2018, 43(5):128-133.
[4] 刘妮妮, 陈庆云. 抓住机遇发展云南实验动物产业[J]. 2011, 24(6):57-59. DOI:10.3969/j.issn.1004-1168.2011.06.021.
[5] 龙云锋. 不断加强实验动物管理助推生物医药产业发展[J]. 云南科技管理, 2015, 28(3):32-35. DOI:10.3969/j.issn.1004-1168.2015.03.009.
[6] 龙云锋. 云南省实验动物现状与加快发展的思考[J]. 云南科技管理, 2016, 29(1):16-19.
[7] ZHOU Y, LI J X, JIN P F, et al.Enterovirus 71: a whole virion inactivated Enterovirus 71 vaccine[J]. Expert Rev Vaccines, 2016, 15(7):803-813. DOI:10.1080/14760584.2016.1191357.
[8] ZHANG Y, WANG L, LIAO Y, et al.Similar protective immunity induced by an inactivated Enterovirus 71 (EV71) vaccine in neonatal rhesus macaques and children[J]. Vaccine, 2015, 33(46):6290-6297. DOI:10.1016/j.vaccine.2015.09.047.
[9] XIANG L F, YIN Y, ZHENG Y, et al.A developmental landscape of 3D-cultured human pre-gastrulation embryos[J]. Nature, 2020, 577(7791):537-542. DOI:10.1038/s41586-019-1875-y.
[10] NIU Y Y, SUN N Q, LI C, et al. Dissecting primate early post-implantation development using long-term in vitro embryo culture[J]. Science, 2019, 366(6467): eaaw5754. DOI:10.1126/science.aaw5754.
[11] CHEN Y, YU J, NIU Y, et al. Modeling rett syndrome using TALEN-edited MECP₂ mutant cynomolgus monkeys[J]. Cell, 2017, 169(5):945-955.e10. DOI:10.1016/j.cell.2017.04.035.
[12] CHEN Y C, ZHENG Y H, KANG Y, et al.Functional disruption of the dystrophin gene in rhesus monkey using CRISPR/Cas9[J]. Hum Mol Genet, 2015, 24(13):3764-3774. DOI:10.1093/hmg/ddv120.
[13] NIU Y, SHEN B, CUI Y, et al.Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos[J]. Cell, 2014, 156(4):836-843. DOI:10.1016/j.cell.2014.01.027.
[14] HE Y X, LUO X, ZHOU B, et al.Long-read assembly of the Chinese rhesus macaque genome and identification of ape-specific structural variants[J]. Nat Commun, 2019, 10(1):1-14. DOI:10.1038/s41467-019-12174-w.
[15] SAMUELS B C, SIEGWART J T, ZHAN W, et al.A novel tree shrew (Tupaia belangeri) model of Glaucoma[J]. Invest Ophthalmol Vis Sci, 2018, 59(7):3136-3143. DOI:10.1167/iovs.18-24261.
[16] 王文广, 黄晓燕, 徐娟, 等. EV71可感染幼龄中缅树鼩[J]. 动物学研究, 2012, 33(1):7-13.
[17] XIAO J, LIU R, CHEN C S.Tree shrew (Tupaia belangeri) as a novel laboratory disease animal model[J]. Zool Res, 2017, 38(3):127-137. DOI:10.24272/j.issn.2095-8137.2017.033.
[18] JIA J, WANG W, KUANG D, et al.mRNA profiling reveals response regulators of decreased fungal keratitis symptoms in a tree shrew model[J]. Gene, 2020, 737:144450. DOI:10.1016/j.gene.2020.144450.
[19] XU S, LI X Y, YANG J Y, et al.Comparative pathogenicity and transmissibility of pandemic H1N1, avian H5N1, and human H7N9 influenza viruses in tree shrews[J]. Front Microbiol, 2019, 10:2955. DOI:10.3389/fmicb.2019.02955.
[20] ZHENG H, NIU S, ZHAO H, et al.Donepezil improves the cognitive impairment in a tree shrew model of Alzheimer's disease induced by amyloid-β_1-40 via activating the BDNF/TrkB signal pathway[J]. Metab Brain Dis, 2018, 33(6):1961-1974. DOI:10.1007/s11011-018-0303-6.
[21] TU Q, YANG D, ZHANG X N, et al.A novel pancreatic cancer model originated from transformation of acinar cells in adult tree shrew, a primate-like animal[J]. Dis Model Mech, 2019: dmm038703. DOI:10.1242/dmm.038703.
[22] LI J, WANG W, TONG P, et al.Autophagy induction by HIV-tat and methamphetamine in primary midbrain neuronal cells of tree shrews via the mTOR signaling and ATG5/ATG7 pathway[J]. Front Neurosci, 2018, 12:921. DOI:10.3389/fnins.2018.00921.
[23] FENG Y, FENG Y M, LU C, et al.Tree shrew, a potential animal model for hepatitis C, supports the nfection and replication of HCV in vitro and in vivo[J]. J Gen Virol, 2017, 98(8):2069-2078. DOI:10.1099/jgv.0.000869.
[24] FAN Y, HUANG Z Y, CAO C C, et al.Genome of the Chinese tree shrew[J]. Nat Commun, 2013, 4:1426. DOI:10.1038/ncomms2416.
[25] LI C H, YAN L Z, BAN W Z, et al.Long-term propagation of tree shrew spermatogonial stem cells in culture and successful generation of transgenic offspring[J]. Cell Res, 2017, 27(2):241-252. DOI:10.1038/cr.2016.156.
[26] NIU D, WEI H J, LIN L, et al.Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9[J]. Science, 2017, 357(6357):1303-1307. DOI:10.1126/science.aan4187.
[27] YU H H, ZHAO H, QING Y B, et al.Porcine zygote injection with Cas9/sgRNA results in DMD-modified pig with muscle dystrophy[J]. Int J Mol Sci, 2016, 17(10):1668. DOI:10.3390/ijms17101668.
[28] SHEN Y F, XU K X, YUAN Z M, et al.Efficient generation of P53 biallelic knockout Diannan miniature pigs via TALENs and somatic cell nuclear transfer[J]. J Transl Med, 2017, 15(1):1-11. DOI:10.1186/s12967-017-1327-0.
[29] YAN S, TU Z C, LIU Z M, et al. A huntingtin knockin pig model recapitulates features of selective neurodegeneration in Huntington's disease[J]. Cell, 2018, 173(4):989-1002.e13. DOI:10.1016/j.cell. 2018. 03.005.
[30] 贺争鸣. 基于能力提升的我国实验动物资源发展愿景[J]. 实验动物与比较医学, 2021, 41(2):85-90.DOI: 10.12300/j.issn.1674-5817.2021.042.
[31] 贺争鸣, 陈振文, 代解杰, 等. 实验动物品种增量建设与野生动物科学利用现状与建议[J]. 中国科技资源导刊, 2021, 53(2):50-58.
[32] 王锡乐, 巩薇, 胡建武, 等. 我国实验动物科技工作发展的政策支撑与思考[J]. 实验动物科学, 2020, 37(4):64-68.